Yüklüyor......
Clinical Outcomes and Correlates of TP53 Mutations and Cancer
The initial observation that p53 accumulation might serve as a surrogate biomarker for TP53 mutation has been the cornerstone for vast translational efforts aimed at validating its clinical use for the diagnosis, prognosis, and treatment of cancer. Early on, it was realized that accurate evaluation...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cold Spring Harbor Laboratory Press
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2829964/ https://ncbi.nlm.nih.gov/pubmed/20300207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a001016 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|